Article
Niclosamide potentiates TMEM16A and induces vasoconstriction
2023-08-02
Abstract excerpt
<h4>ABSTRACT</h4> The TMEM16A calcium-activated chloride channel is a promising therapeutic target for various diseases. Niclosamide, an anthelmintic medication, has been considered as a TMEM16A inhibitor for treating asthma and chronic obstructive pulmonary disease, but was recently found to possess broad-spectrum off-target effects. Here we show that, under physiological conditions, niclosamide acutely potentia...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c7eb1477-279c-5095-8598-ac681d19ac14
- DOI
- 10.1101/2023.07.31.551400
